Abstract
Hepatobiliary and pancreatic interventions include a diverse variety of procedures for diagnostic and therapeutic purposes. Liver biopsy is a common diagnostic procedure undertaken to obtain tissue samples for pathology. Percutaneous biliary drainage and cholecystostomy drainage decompresses the biliary system in patients not suitable for more invasive procedures. Transarterial chemoembolization (TACE) is a therapeutic procedure used to induce selective ischemia of the tumor bed in hepatocellular carcinoma. This chapter describes the indication, contraindication, techniques, and complications of these common hepatobiliary and pancreatic procedures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Krokidis M, Orgera G, Rossi M, et al. Interventional radiology in the management of benign biliary stenoses, biliary leaks and fistulas: a pictorial review. Insights Imaging. 2013;4(1):77–84.
Little MW, Briggs JH, Tapping CR, et al. Percutaneous cholecystostomy: the radiologist’s role in treating acute cholecystitis. Clin Radiol. 2013;68(7):654–60.
Thompson Coon J, Rogers G, Hewson P, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess. 2007;11(34):1–206.
Singal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomark Prev. 2012;21(5):793–9.
Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.
Vauthey JN, Dixon E, Abdalla EK, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12(5):289–99.
Kadri HS, Blank S, Wang Q, et al. Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis B and minimally fibrotic liver. Eur J Surg Oncol. 2013;39(12):1371–6.
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
Kennedy SA, Gopee-Ramanan P, Dath D. Hepatocellular carcinoma: a clinical review. MUMJ. 2014;11(1):9–14.
Tang A, Cruite I, Sirlin CB. Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI. Expert Rev Gastroenterol Hepatol. 2013;7(3):269–79.
Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28–36.
Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31(4):426–32.
Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol. 2013;30(1):3–11.
Raoul JL, Sangro B, Forner A, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev. 2011;37(3):212–20.
Steward MJ, Warbey VS, Malhotra A, et al. Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics. 2008;28(4):1131–45.
Bester L, Meteling B, Boshell D, et al. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature. J Med Imaging Radiat Oncol. 2014;58(3):341–52.
Salem R, Lewandowski R, Atassi B. Treatment of unresectable hepatocellular carcinoma with use of Y90 microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16:1627–39.
Woerner AJ, Johnson GE. Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma. Hepatoma Res. 2022;8:2.
Fiorentini G, Sarti D, Nani R, Aliberti C, Fiorentini C, Guadagni S. Updates of colorectal cancer liver metastases therapy: review on DEBIRI. Hepat Oncol. 2020;7(1):HEP16.
Acknowledgment
We would like to thank Dr. Prasaanthan Gopee-Ramanan for his contributions to this chapter (information given on first page of chapter).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Liu, E., Gopee-Ramanan, P. (2022). Hepatobiliary and Pancreatic Interventions. In: Athreya, S., Albahhar, M. (eds) Demystifying Interventional Radiology. Springer, Cham. https://doi.org/10.1007/978-3-031-12023-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-031-12023-7_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-12022-0
Online ISBN: 978-3-031-12023-7
eBook Packages: MedicineMedicine (R0)